Clinical Pharmacologist/Director
Pfizer Inc.
Dr. Cheng Chang is a director of clinical pharmacology at Pfizer. He has more than 15 years of experience on the application of pharmacometric and clinical pharmacology approaches that facilitate decision making in all stages of drug discovery and development including applying translational PK/PD analyses to guide the design of multiple positive proof of mechanism studies; developing MIDD strategies to accelerate the phase 3 study start as well as waiving post-marketing required clinical studies. He has authored over 45 peer-reviewed research papers, review articles and book chapters.
Rapid Fires: Advancing Innovation in In Silico Translational Approaches 2
Tuesday, October 24, 2023
3:00 PM – 4:00 PM ET
Translational Analysis Across Formulations/Populations to Support a Pediatric Formulation Approval
Tuesday, October 24, 2023
3:45 PM – 4:00 PM ET